Fighting the pandemic with HPC
This edition of the PRACE Digest focusses entirely on projects awarded under the PRACE Fast Track Call for Proposals to mitigate the impact of the COVID-19 pandemic.
PRACE opened this Call for Proposals in early spring as an urgent computing answer to the need for fast scientific discovery to find ways to stop the spread of SARS-CoV-2, reduce its impact on our health and economy, and find treatments for people affected by the disease.
A Scientific Committee of five high-level researchers has been leading the review process and evaluating proposals within one week. Selected projects are given access to the Europe’s most powerful supercomputers. Those projects can also receive data storage and sharing solutions, e.g. from FENIX and ICEI, in line with the open data policy applicable to the Call.
Over 80 project applications have been received and, with an acceptance rate of less than 50%, just over 30 projects have been awarded time on one of PRACE’s world-class systems. In total, half a billion computational hours have been awarded over a period of six months.
The pandemic has brought researchers together like never before, encouraging collaboration across all disciplines in order to find answers in a time when we need them most. Projects awarded under the Fast Track Call come from fields such as biomolecular simulations, bioinformatics, epidemiology, computational fluid dynamics, screening and docking, among others. Furthermore, monthly webinars have been organised with our colleagues in the USA, where project leaders from around the world have presented their work and exchanged on solutions and collaborations concerning the pandemic research.
I highly encourage you take inspiration from the articles in this edition of the PRACE Digest to develop further innovations to tackle the coronavirus pandemic.
Please also save the dates of the next edition of the EuroHPC Summit Week, which will be held digitally from 22 to 26 March 2021, and which will include an entire day of talks and presentations of COVID-19 related research.